Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GoodSense is a metabolic health company that leverages continuous glucose monitoring (CGM) and artificial intelligence to provide personalized, data-driven nutrition and lifestyle interventions. The company's platform analyzes individual glycemic responses to various foods and activities, offering real-time guidance to help users manage or prevent metabolic conditions such as Type 2 diabetes, prediabetes, and obesity. By combining wearable sensor technology with proprietary algorithms, GoodSense aims to improve long-term health outcomes through precision metabolic management. The company primarily operates as a digital health provider, offering a subscription-based service that includes hardware and a mobile application.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Good Sense.